A detailed history of Shelton Capital Management transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Shelton Capital Management holds 13,600 shares of XBI stock, worth $1.24 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
13,600
Previous 13,600 -0.0%
Holding current value
$1.24 Million
Previous $1.21 Million 6.26%
% of portfolio
0.04%
Previous 0.04%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$87.05 - $102.89 $1.18 Million - $1.4 Million
13,600 New
13,600 $1.29 Million
Q3 2023

Nov 14, 2023

BUY
$71.88 - $85.76 $977,567 - $1.17 Million
13,600 New
13,600 $993,000
Q2 2023

Aug 10, 2023

BUY
$75.38 - $90.23 $1.03 Million - $1.23 Million
13,600 New
13,600 $1.13 Million
Q4 2022

Feb 13, 2023

BUY
$77.2 - $85.66 $1.06 Million - $1.17 Million
13,680 New
13,680 $1.14 Million
Q3 2022

Nov 14, 2022

BUY
N/A
13,600 New
13,600 $1.08 Million
Q4 2020

Feb 16, 2021

BUY
N/A
2,800 Added 25.93%
13,600 $1.92 Million
Q3 2020

Nov 09, 2020

SELL
N/A
-1,200 Reduced 10.0%
10,800 $1.2 Million
Q4 2019

Feb 11, 2020

BUY
N/A
12,000 New
12,000 $1.14 Million

Others Institutions Holding XBI

About SPDR SER TR SPDR S&P BIOTECH E


  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.